Eva Hofsli

5PUBLICATIONS

25CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 20, 2026

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

|Oct 19, 2023

Design, Development, and Evaluation of an mHealth App for Reporting of Side Effects During Cytostatic Treatment: Usability Test and Interview Study.

Emil Aale Hægermark, Nina Kongshaug, Sunil Xavier Raj

|Oct 14, 2022

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study.

Gabor Liposits, Halla Skuladottir, Jesper Ryg

|Jan 06, 2021

Cancer Patients' Perceived Value of a Smartphone App to Enhance the Safety of Home-Based Chemotherapy: Feasibility Study.

Nina Kongshaug, John-Arne Skolbekken, Arild Faxvaag

|Oct 08, 2020

Physical exercise during adjuvant chemotherapy for colorectal cancer-a non-randomized feasibility study.

I Hatlevoll, L M Oldervoll, A Wibe

Pageof 1

Frequent Collaborators

Nina Kongshaug

Arild Faxvaag

I Hatlevoll

L M Oldervoll

A Wibe

G B Stene

S N Stafne

John-Arne Skolbekken

Gabor Liposits

Jesper Ryg

Frequent Collaborators

Nina Kongshaug

Arild Faxvaag

I Hatlevoll

L M Oldervoll